CB-1158 treatment as monotherapy, or in combination with anti-PD-1 checkpoint inhibitor, decreased tumor growth in vivo in mice with Lewis lung carcinoma (Steggerda et al., 2017). This evidence concerns the gene PDCD1 and neoplasm.